Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prasad Mathew

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Obstetrics and Gynecology|May 4, 2004
Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancyShakil H Merchant, Prasad Mathew, Timothy J Vanderjagt, et al.
Blood Reviews|May 24, 2021
Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021Alessandro Di Minno, Gaia Spadarella, Salvatore Esposito, et al.
Expert Review of Hematology|November 15, 2016
Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experienceOlubunmi Afonja, Robert Kozak, Paul Petraro, et al.
Journal of Pediatric Hematology/Oncology|June 10, 2003
Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseasesPrasad Mathew, Stuart S Winter, Jami D Frost, et al.
Thrombosis and Haemostasis|October 17, 2007
Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trialRajiv K Pruthi, Prasad Mathew, Leonard A Valentino, et al.
Seminars in Thrombosis and Hemostasis|December 22, 2011
Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studiesChristoph Bidlingmaier, Gili Kenet, Karin Kurnik, et al.
AIDS (London, England)|July 17, 2007
Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophiliaLehida Melendez-Morales, Barbara A Konkle, Liliana Preiss, et al.
Pediatric Blood & Cancer|May 16, 2015
Health economic models in hemophilia A and utility assumptions from a clinician's perspectiveMichele Valente, Paolo A Cortesi, Giuseppe Lassandro, et al.
Journal of Global Infectious Diseases|December 25, 2014
Kikuchi-fujimoto disease: clinical and laboratory characteristics and outcomePs Rakesh, Reginald G Alex, George M Varghese, et al.
Ejhaem|December 5, 2022
Prophylaxis and hemophilia care in LATAM: Baring it all-Highlights from the CLAHT 2021 symposiumGiovanni G DiMinno, Lida Milena Araujo Cabrera, Nancy Loayza Urcia, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology|May 4, 2004
Recombinant factor VIIa in management of spontaneous subcapsular liver hematoma associated with pregnancyShakil H Merchant, Prasad Mathew, Timothy J Vanderjagt, et al.
Blood Reviews|May 24, 2021
Perspective - The case for zero bleeds and drug bioequivalence in the treatment of congenital hemophilia A in 2021Alessandro Di Minno, Gaia Spadarella, Salvatore Esposito, et al.
Expert Review of Hematology|November 15, 2016
Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experienceOlubunmi Afonja, Robert Kozak, Paul Petraro, et al.
Journal of Pediatric Hematology/Oncology|June 10, 2003
Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseasesPrasad Mathew, Stuart S Winter, Jami D Frost, et al.
Thrombosis and Haemostasis|October 17, 2007
Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trialRajiv K Pruthi, Prasad Mathew, Leonard A Valentino, et al.
Seminars in Thrombosis and Hemostasis|December 22, 2011
Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studiesChristoph Bidlingmaier, Gili Kenet, Karin Kurnik, et al.
AIDS (London, England)|July 17, 2007
Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophiliaLehida Melendez-Morales, Barbara A Konkle, Liliana Preiss, et al.
Pediatric Blood & Cancer|May 16, 2015
Health economic models in hemophilia A and utility assumptions from a clinician's perspectiveMichele Valente, Paolo A Cortesi, Giuseppe Lassandro, et al.
Journal of Global Infectious Diseases|December 25, 2014
Kikuchi-fujimoto disease: clinical and laboratory characteristics and outcomePs Rakesh, Reginald G Alex, George M Varghese, et al.
Ejhaem|December 5, 2022
Prophylaxis and hemophilia care in LATAM: Baring it all-Highlights from the CLAHT 2021 symposiumGiovanni G DiMinno, Lida Milena Araujo Cabrera, Nancy Loayza Urcia, et al.
Pageof 5